K946059 is an FDA 510(k) clearance for the CEDIA(R) DAU PCP ASSAY. Classified as Enzyme Immunoassay, Phencyclidine (product code LCM).
Submitted by Microgenics Corp. (Concord, US). The FDA issued a Cleared decision on January 17, 1995 after a review of 36 days - a notably fast clearance cycle.
This device falls under the Toxicology FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Microgenics Corp. devices